| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $70.1M | +117.5% |
| SG&A Expense | $15.2M | -7.8% |
| Operating Income | -$85.3M | -75.1% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$78.5M | -95.3% |
| EPS (Basic) | -$5.90 | -60.3% |
| EPS (Diluted) | -$5.90 | -60.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.5M | +65.7% |
| Short-term Investments | $134.8M | +2.2% |
| Current Assets | $167.0M | +9.1% |
| Total Assets | $168.2M | +7.9% |
| Current Liabilities | $20.7M | +75.1% |
| Total Liabilities | $20.7M | +53.8% |
| Stockholders' Equity | $147.5M | +3.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.5M | -54.3% |
| Capital Expenditures | $7K | — |
| Investing Cash Flow | -$1.6M | +98.6% |
| Financing Cash Flow | $77.4M | -53.5% |
| Free Cash Flow | -$64.5M | -54.3% |